Unfortunately, most studies that have focused on the effect of various foods on aromatase inhibition have been primarily interested in the potential clinical use for treatment or prevention of various diseases such as breast cancer, and not on the ergogenic potential that they may have for competitive athletes. The gene discussed is CYP19A1; the disease is breast cancer.